CardioMech Mitral Valve Repair System (MVRS)

CardioMech is developing a transfemoral transseptal mitral valve repair technology to specifically treat patients suffering from moderate to severe or severe, symptomatic DMR due to prolapse or flail.

The CardioMech MVRS technology is designed to provide a fully percutaneous catheter-based therapy for the placement of artificial chord(s) to eliminate MR as an alternative to surgical mitral valve repair.

About CardioMech:

CardioMech AS is a privately held company that is developing a transcatheter mitral valve repair technology to treat cardiac patients with a leaky mitral valve.  For more information, visit https//www.cardiomech.com

Caution: The CardioMech device is in the early R&D development phase and is NOT approved or cleared by the FDA or any other regulatory body in any region of the world.